Creatine, Carnitine and Carnosine in Vegetarians
Effect of a 6-month Vegetarian Diet in Omnivorous Women on Body Creatine, Carnitine and Carnosine Stores
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Balanced vegetarian diets are popular and contain health-promoting characteristics. A balanced lacto-ovo-vegetarian diet differs in nutrient intake from an omnivorous diet, e.g. by increased intake of fibre, magnesium and antioxidants, but lower intake of omega-3 fatty acids and vitamin B12. However, the impact of reduced to near absent intake of carnitine, carnosine and creatine in a vegetarian diet is less well established and could be relevant in relation to muscle function, exercise capacity and sports performance. Few longitudinal intervention studies investigating the effect of a vegetarian diet on the availability of these compounds currently exist. This study aimed therefore to investigate the effect of of transiently switching omnivores onto a vegetarian diet for 6 months on muscle and plasma creatine, carnitine and carnosine homeostasis. We hypothesized that homeostasis of creatine and carnosine would be disrupted when their dietary intake was missing. For carnitine, however, we hypothesized that homeostasis can be maintained given its slow turnover rate and its presence in some non-meat nutrients. A second aim was to investigate whether supplementation of creatine and beta-alanine (the rate-limiting precursor of carnosine synthesis), concurrently with a lacto-ovo-vegetarian diet, was able to correct for potentially emerging deficiencies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2012
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 15, 2017
CompletedFirst Posted
Study publicly available on registry
June 21, 2017
CompletedResults Posted
Study results publicly available
February 28, 2019
CompletedFebruary 28, 2019
October 1, 2018
6 months
June 15, 2017
July 31, 2017
October 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (14)
Fasted Plasma Beta-alanine Concentration
Fasted venous plasma beta-alanine concentration (precursor for carnosine) at 0, 3 and 6 months of the intervention
6 months
Gastrocnemius Carnosine Concentration
Gastrocnemius carnosine concentration at 0, 3 and 6 months of the intervention
6 months
Soleus Carnosine Concentration
Soleus carnosine concentration at 0, 3 and 6 months of the intervention
6 months
Plasma Creatine Concentration
Plasma creatine concentration at 0, 3 and 6 months of the intervention
6 months
Plasma Creatinine Concentration
Plasma creatinine at 0, 3 and 6 months of the intervention
6 months
Plasma Guanidinoacetate Concentration
Plasma guanidinoacetate at 0, 3 and 6 months of the intervention
6 months
Urinary Creatinine Concentration
Urinary creatinine at 0, 3 and 6 months of the intervention
6 months
Muscle Creatine Concentration
Muscle total creatine concentration in vastus lateralis muscle at 0 and 3 months of the intervention
3 months
Plasma Carnitine Concentration
plasma free carnitine concentration at 0, 3 and 6 months of the intervention
6 months
Plasma Acetylcarnitine Concentration
plasma acetylcarnitine concentration at 0, 3 and 6 months of the intervention
6 months
Plasma Total Carnitine Concentration
plasma total carnitine concentration (free + acetyl) at 0, 3 and 6 months of the intervention
6 months
Muscle Carnitine Concentration
muscle free carnitine concentration in vastus lateralis muscle at 0 and 3 months of the intervention
3 months
Muscle Acetylcarnitine Concentration
muscle acetylcarnitine concentration in vastus lateralis muscle at 0 and 3 months of the intervention
3 months
Muscle Total Carnitine Concentration
muscle total carnitine concentration (free + acetylcarnitine) in vastus lateralis muscle at 0 and 3 months of the intervention
3 months
Secondary Outcomes (8)
Vitamin D Status
6 months
Urinary Biomarker for Meat Intake: Pi-methyl-histidine
6 months
Urinary Biomarker for Meat Intake: Tau-methyl-histidine
6 months
Urinary Biomarker for Meat Intake: Anserine
6 months
VO2max
6 months
- +3 more secondary outcomes
Study Arms (3)
Control
NO INTERVENTIONcontinued their omnivorous diet throughout the entire study
Veg+Pla
EXPERIMENTALvegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine
Veg+ creatine and beta-alanine
EXPERIMENTALswitch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day
Interventions
Eligibility Criteria
You may qualify if:
- women
You may not qualify if:
- smoking, chronic use of medication or taking supplements, athletes participating in competitions, vegetarianism or eating meat or fish less than 5 times a week
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
Related Publications (2)
Van Dyck D, Herman K, Poppe L, Crombez G, De Bourdeaudhuij I, Gheysen F. Results of MyPlan 2.0 on Physical Activity in Older Belgian Adults: Randomized Controlled Trial. J Med Internet Res. 2019 Oct 7;21(10):e13219. doi: 10.2196/13219.
PMID: 31593541DERIVEDBlancquaert L, Baguet A, Bex T, Volkaert A, Everaert I, Delanghe J, Petrovic M, Vervaet C, De Henauw S, Constantin-Teodosiu D, Greenhaff P, Derave W. Changing to a vegetarian diet reduces the body creatine pool in omnivorous women, but appears not to affect carnitine and carnosine homeostasis: a randomised trial. Br J Nutr. 2018 Apr;119(7):759-770. doi: 10.1017/S000711451800017X.
PMID: 29569535DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Limitations and Caveats
A far too low number of subjects consented to have muscle biopsies taken at 6M. Therefore, muscle analyses were restricted to the 0 and 3M time points.
Results Point of Contact
- Title
- Prof. Wim Derave
- Organization
- University Ghent
Study Officials
- PRINCIPAL INVESTIGATOR
Wim Derave, Professor
University Ghent
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- A co-worker, not involved in the study design and analysis, will perform the randomisation and will prepare the containers with supplements. Only the control group will know that they are part of the control group (continuing omnivorous diet). For the vegetarian groups, subject will not know whether they are in the supplemented group or not because placebo supplements will be used
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2017
First Posted
June 21, 2017
Study Start
December 1, 2012
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
February 28, 2019
Results First Posted
February 28, 2019
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share
individual data will not be made available to other researchers